A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Clinical trial NCT05150691 · RECRUITING

Trial details

NCT number: NCT05150691
Sponsor: DualityBio Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2-positive Advanced Solid Tumor

Start date: 2022-01-31
Primary completion: 2026-04-01
Enrollment: 796

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.